NEW YORK, Oct. 9 (GenomeWeb News) - Massachusetts General Hospital and CytRx try to use RNAi technology to develop a drug to prevent and cure amyotrophic lateral sclerosis, the groups said today.
   
The agreement comes on the heels of an RNAi-based research program CytRx penned with the University of Massachusetts Medical School - from which the company recently acquired an exclusive licenses to the RNAi technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.